Allopurinol and the role of uric acid in hypertension

JAMA

Volumn 301, Issue 3, 2009, Pages 270-

  Brinker, Allen D ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; PLACEBO; URIC ACID; ENZYME INHIBITOR; XANTHINE OXIDASE;

ALLERGIC REACTION; BLOOD PRESSURE; DRUG EFFICACY; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HUMAN; HYPERSENSITIVITY REACTION; HYPERTENSION; KIDNEY FAILURE; LETTER; LIVER TOXICITY; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PURPURA; RASH; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; STROKE; TREATMENT INDICATION; URIC ACID BLOOD LEVEL; URTICARIA; VASCULITIS; ADOLESCENT; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG ERUPTION; NOTE;

ADOLESCENT; ALLOPURINOL; DRUG ERUPTIONS; ENZYME INHIBITORS; HUMANS; HYPERTENSION; STEVENS-JOHNSON SYNDROME; URIC ACID; XANTHINE OXIDASE;

EID: 58749099784     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.1013     Document Type: Letter

References (4)

1. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300(8):924-932.
2. About DailyMed. DailyMed Current Medication Information Web site. http://dailymed.nlm.nih.gov/dailymed/about.cfm. Accessed October 20, 2008.
3. McInnes GT, Lawson DH, Jick H. Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis. 1981;40(3):245-249.
4. Johnson RJ, Feig DI, Nakagawa T, Sanchez-Lozada LG, Rodriguez-Iturbe B. Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens. 2008;26(3):381-391.